Product research overview
KPV (Lys-Pro-Val) is a tripeptide corresponding to the C-terminal fragment of alpha-melanocyte-stimulating hormone. Laboratory studies have focused on epithelial transport, inflammatory signaling, and barrier-model biology.
Muscle & Recovery
kpv
10mg/vial
Small peptide fragment often studied around inflammation, skin-barrier, and gut-barrier models.
€55,00
Third-party testedCOA availableEU shippingResearch only
For in-vitro laboratory research only. Not for human or veterinary use.This information is provided for scientific and educational product context only. It does not describe or recommend human use, veterinary use, diagnosis, treatment, prevention, dosage, administration, or clinical application.
Research intelligence
Research context for KPV
This information is provided for scientific and educational product context only. It does not describe or recommend human use, veterinary use, diagnosis, treatment, prevention, dosage, administration, or clinical application.
MaterialAlpha-MSH-related tripeptide
Primary areaEpithelial and inflammatory models
EvidenceCell and barrier-model literature
CatalogMuscle & Recovery
Mechanism & pathway context
- Intestinal-cell literature has examined PepT1-mediated uptake and downstream inflammatory signaling.
- Additional experimental work considers melanocortin-related biology, epithelial repair, and nitric-oxide-associated wound-model endpoints.
Epithelial transport
Peptide uptake and transporter-dependent cell models.
Inflammatory signaling
Cytokine and pathway markers in controlled systems.
Barrier biology
Intestinal and skin/corneal epithelial model endpoints.
Melanocortin context
Fragment biology related to alpha-MSH research.
What researchers study
- PepT1-dependent peptide transport
- NF-kB and cytokine-associated readouts
- Epithelial migration and barrier markers
- Cell culture and animal inflammation endpoints
Current evidence snapshot
| Evidence area | Research context | Strength | Notes |
|---|---|---|---|
| Intestinal inflammation | Cell and mouse models | Preclinical | Transport and inflammatory markers were examined. |
| Epithelial repair | Rabbit corneal model | Preclinical | Fragment effects were studied in an injury model. |
| Human outcomes | Controlled clinical evidence | Limited | No product-level clinical conclusion can be drawn. |
Limitations & safety boundaries
- This storefront supplies research reference material only; research findings do not establish consumer outcomes.
- Evidence may be limited to cell, tissue, or animal models and may not translate to humans.
- No dosing, administration, preparation, or clinical guidance is provided.
- Researchers and buyers are responsible for institutional requirements and applicable local laws.
For in-vitro laboratory research only. Not for human or veterinary use.